Studies on the Identity of a Vascular Permeability Factor of Renal Origin

1970 ◽  
Vol 38 (3) ◽  
pp. 309-325 ◽  
Author(s):  
M. F. Cuthbert ◽  
W. S. Peart

1. The administration of crude renal extract to bilaterally nephrectomized rats causes an increase in vascular permeability to plasma proteins. This is associated with a fall in plasma volume. The active material resembles the enzyme renin in pressor activity, heat-lability, pH range of activity and molecular size. 2. To test the possibility that renin might be responsible, renin was extracted from rat renal cortical tissue using methods similar to those used for the purification of pig renin: these involved saline extraction, protein precipitation, freeze drying, ion-exchange and gel-filtration. 3. The final preparation had a pressor activity some 300 times that of the initial saline extract and gel-filtration suggested that the molecular size of rat renin is 40 000–50 000. Assay for pressor and vascular permeability activity at selected stages in the purification showed that both activities ran parallel and could not be dissociated. These results provide strong evidence that the vascular permeability factor is in fact renin. 4. Increase in vascular permeability after injection of semi-purified material could still be demonstrated after bilateral adrenalectomy, though the effect was reduced. 5. In all experiments in which vascular permeability was increased and in which blood pressure was measured, a considerable and sustained rise in blood pressure occurred. It is possible that the increase in blood pressure is causally related to the increase in permeability.

2002 ◽  
Vol 196 (11) ◽  
pp. 1497-1506 ◽  
Author(s):  
Janice A. Nagy ◽  
Eliza Vasile ◽  
Dian Feng ◽  
Christian Sundberg ◽  
Lawrence F. Brown ◽  
...  

Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF, VEGF-A) is a multifunctional cytokine with important roles in pathological angiogenesis. Using an adenoviral vector engineered to express murine VEGF-A164, we previously investigated the steps and mechanisms by which this cytokine induced the formation of new blood vessels in adult immunodeficient mice and demonstrated that the newly formed blood vessels closely resembled those found in VEGF-A–expressing tumors. We now report that, in addition to inducing angiogenesis, VEGF-A164 also induces a strong lymphangiogenic response. This finding was unanticipated because lymphangiogenesis has been thought to be mediated by other members of the VPF/VEGF family, namely, VEGF-C and VEGF-D. The new “giant” lymphatics generated by VEGF-A164 were structurally and functionally abnormal: greatly enlarged with incompetent valves, sluggish flow, and delayed lymph clearance. They closely resembled the large lymphatics found in lymphangiomas/lymphatic malformations, perhaps implicating VEGF-A in the pathogenesis of these lesions. Whereas the angiogenic response was maintained only as long as VEGF-A was expressed, giant lymphatics, once formed, became VEGF-A independent and persisted indefinitely, long after VEGF-A expression ceased. These findings raise the possibility that similar, abnormal lymphatics develop in other pathologies in which VEGF-A is overexpressed, e.g., malignant tumors and chronic inflammation.


Sign in / Sign up

Export Citation Format

Share Document